持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/26 | 3,355 | 3,360 | 3,280 | 3,290 | -60 | -1.8% | 45,900 |
| 2022/09/22 | 3,335 | 3,375 | 3,325 | 3,350 | -10 | -0.3% | 32,700 |
| 2022/09/21 | 3,325 | 3,375 | 3,325 | 3,360 | -35 | -1% | 33,100 |
| 2022/09/20 | 3,380 | 3,405 | 3,365 | 3,395 | +25 | +0.7% | 33,200 |
| 2022/09/16 | 3,345 | 3,395 | 3,345 | 3,370 | +25 | +0.7% | 36,800 |
| 2022/09/15 | 3,365 | 3,370 | 3,340 | 3,345 | -15 | -0.4% | 28,400 |
| 2022/09/14 | 3,330 | 3,375 | 3,330 | 3,360 | -80 | -2.3% | 31,900 |
| 2022/09/13 | 3,450 | 3,460 | 3,435 | 3,440 | -5 | -0.1% | 17,500 |
| 2022/09/12 | 3,455 | 3,460 | 3,420 | 3,445 | +20 | +0.6% | 24,000 |
| 2022/09/09 | 3,400 | 3,450 | 3,400 | 3,425 | +30 | +0.9% | 49,400 |
| 2022/09/08 | 3,330 | 3,410 | 3,330 | 3,395 | +115 | +3.5% | 63,100 |
| 2022/09/07 | 3,310 | 3,330 | 3,265 | 3,280 | -30 | -0.9% | 37,700 |
| 2022/09/06 | 3,390 | 3,410 | 3,310 | 3,310 | -65 | -1.9% | 29,300 |
| 2022/09/05 | 3,355 | 3,375 | 3,310 | 3,375 | +15 | +0.4% | 35,700 |
| 2022/09/02 | 3,410 | 3,410 | 3,345 | 3,360 | -20 | -0.6% | 34,000 |
| 2022/09/01 | 3,400 | 3,400 | 3,345 | 3,380 | -55 | -1.6% | 50,000 |
| 2022/08/31 | 3,370 | 3,450 | 3,370 | 3,435 | +20 | +0.6% | 92,000 |
| 2022/08/30 | 3,370 | 3,420 | 3,370 | 3,415 | +45 | +1.3% | 35,000 |
| 2022/08/29 | 3,330 | 3,380 | 3,330 | 3,370 | -40 | -1.2% | 44,300 |
| 2022/08/26 | 3,440 | 3,445 | 3,410 | 3,410 | -15 | -0.4% | 26,900 |
| 2022/08/25 | 3,410 | 3,455 | 3,405 | 3,425 | +15 | +0.4% | 30,800 |
| 2022/08/24 | 3,410 | 3,415 | 3,375 | 3,410 | -10 | -0.3% | 40,600 |
| 2022/08/23 | 3,415 | 3,435 | 3,385 | 3,420 | -25 | -0.7% | 36,500 |
| 2022/08/22 | 3,380 | 3,455 | 3,345 | 3,445 | +40 | +1.2% | 38,200 |
| 2022/08/19 | 3,450 | 3,450 | 3,380 | 3,405 | -5 | -0.1% | 29,400 |
| 2022/08/18 | 3,475 | 3,475 | 3,395 | 3,410 | -75 | -2.2% | 36,000 |
| 2022/08/17 | 3,445 | 3,500 | 3,445 | 3,485 | +90 | +2.7% | 64,700 |
| 2022/08/16 | 3,455 | 3,455 | 3,385 | 3,395 | -60 | -1.7% | 24,300 |
| 2022/08/15 | 3,445 | 3,460 | 3,415 | 3,455 | +25 | +0.7% | 26,000 |
| 2022/08/12 | 3,395 | 3,450 | 3,370 | 3,430 | +40 | +1.2% | 43,300 |
| 2022/08/10 | 3,360 | 3,405 | 3,350 | 3,390 | +30 | +0.9% | 25,100 |
| 2022/08/09 | 3,405 | 3,430 | 3,360 | 3,360 | -45 | -1.3% | 25,600 |
| 2022/08/08 | 3,420 | 3,425 | 3,365 | 3,405 | -20 | -0.6% | 29,300 |
| 2022/08/05 | 3,370 | 3,425 | 3,370 | 3,425 | +35 | +1% | 40,400 |
| 2022/08/04 | 3,405 | 3,430 | 3,365 | 3,390 | -15 | -0.4% | 41,400 |
| 2022/08/03 | 3,475 | 3,515 | 3,385 | 3,405 | -55 | -1.6% | 73,000 |
| 2022/08/02 | 3,410 | 3,500 | 3,400 | 3,460 | +60 | +1.8% | 111,500 |
| 2022/08/01 | 3,265 | 3,505 | 3,225 | 3,400 | +140 | +4.3% | 128,900 |
| 2022/07/29 | 3,360 | 3,360 | 3,250 | 3,260 | -90 | -2.7% | 40,500 |
| 2022/07/28 | 3,360 | 3,370 | 3,305 | 3,350 | -10 | -0.3% | 36,200 |
| 2022/07/27 | 3,355 | 3,375 | 3,330 | 3,360 | +5 | +0.1% | 26,000 |
| 2022/07/26 | 3,375 | 3,390 | 3,335 | 3,355 | +5 | +0.1% | 29,500 |
| 2022/07/25 | 3,345 | 3,375 | 3,345 | 3,350 | -35 | -1% | 20,400 |
| 2022/07/22 | 3,380 | 3,415 | 3,380 | 3,385 | +5 | +0.1% | 31,700 |
| 2022/07/21 | 3,335 | 3,390 | 3,310 | 3,380 | +20 | +0.6% | 24,600 |
| 2022/07/20 | 3,325 | 3,370 | 3,290 | 3,360 | +90 | +2.8% | 48,300 |
| 2022/07/19 | 3,305 | 3,305 | 3,245 | 3,270 | -35 | -1.1% | 19,200 |
| 2022/07/15 | 3,360 | 3,360 | 3,285 | 3,305 | -45 | -1.3% | 33,000 |
| 2022/07/14 | 3,330 | 3,350 | 3,320 | 3,350 | ±0 | ±0% | 16,800 |
| 2022/07/13 | 3,355 | 3,365 | 3,330 | 3,350 | +10 | +0.3% | 19,400 |
651～
700
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
